278 related articles for article (PubMed ID: 22220926)
1. Selective small molecule inhibition of poly(ADP-ribose) glycohydrolase (PARG).
Finch KE; Knezevic CE; Nottbohm AC; Partlow KC; Hergenrother PJ
ACS Chem Biol; 2012 Mar; 7(3):563-70. PubMed ID: 22220926
[TBL] [Abstract][Full Text] [Related]
2. ADP-ribosylhydrolase 3 (ARH3), not poly(ADP-ribose) glycohydrolase (PARG) isoforms, is responsible for degradation of mitochondrial matrix-associated poly(ADP-ribose).
Niere M; Mashimo M; Agledal L; Dölle C; Kasamatsu A; Kato J; Moss J; Ziegler M
J Biol Chem; 2012 May; 287(20):16088-102. PubMed ID: 22433848
[TBL] [Abstract][Full Text] [Related]
3. Discovery and structure-activity relationships of modified salicylanilides as cell permeable inhibitors of poly(ADP-ribose) glycohydrolase (PARG).
Steffen JD; Coyle DL; Damodaran K; Beroza P; Jacobson MK
J Med Chem; 2011 Aug; 54(15):5403-13. PubMed ID: 21692479
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of phenolic hydrazide hydrazones as potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors.
Islam R; Koizumi F; Kodera Y; Inoue K; Okawara T; Masutani M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3802-6. PubMed ID: 25042255
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells.
Feng X; Koh DW
Int J Oncol; 2013 Feb; 42(2):749-56. PubMed ID: 23254695
[TBL] [Abstract][Full Text] [Related]
6. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors.
Brosey CA; Houl JH; Katsonis P; Balapiti-Modarage LPF; Bommagani S; Arvai A; Moiani D; Bacolla A; Link T; Warden LS; Lichtarge O; Jones DE; Ahmed Z; Tainer JA
Prog Biophys Mol Biol; 2021 Aug; 163():171-186. PubMed ID: 33636189
[TBL] [Abstract][Full Text] [Related]
7. Targeting poly(ADP-ribose) glycohydrolase to draw apoptosis codes in cancer.
Tanuma SI; Shibui Y; Oyama T; Uchiumi F; Abe H
Biochem Pharmacol; 2019 Sep; 167():163-172. PubMed ID: 31176615
[TBL] [Abstract][Full Text] [Related]
8. Monitoring Poly(ADP-ribosyl)glycohydrolase Activity with a Continuous Fluorescent Substrate.
Drown BS; Shirai T; Rack JGM; Ahel I; Hergenrother PJ
Cell Chem Biol; 2018 Dec; 25(12):1562-1570.e19. PubMed ID: 30318463
[TBL] [Abstract][Full Text] [Related]
9. Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death.
Houl JH; Ye Z; Brosey CA; Balapiti-Modarage LPF; Namjoshi S; Bacolla A; Laverty D; Walker BL; Pourfarjam Y; Warden LS; Babu Chinnam N; Moiani D; Stegeman RA; Chen MK; Hung MC; Nagel ZD; Ellenberger T; Kim IK; Jones DE; Ahmed Z; Tainer JA
Nat Commun; 2019 Dec; 10(1):5654. PubMed ID: 31827085
[TBL] [Abstract][Full Text] [Related]
10. A high-throughput screening-compatible homogeneous time-resolved fluorescence assay measuring the glycohydrolase activity of human poly(ADP-ribose) glycohydrolase.
Stowell AI; James DI; Waddell ID; Bennett N; Truman C; Hardern IM; Ogilvie DJ
Anal Biochem; 2016 Jun; 503():58-64. PubMed ID: 27036617
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel poly(ADP-ribose) glycohydrolase inhibitors by a quantitative assay system using dot-blot with anti-poly(ADP-ribose).
Okita N; Ashizawa D; Ohta R; Abe H; Tanuma S
Biochem Biophys Res Commun; 2010 Feb; 392(4):485-9. PubMed ID: 20079708
[TBL] [Abstract][Full Text] [Related]
12. Expression of poly(ADP-ribose) glycohydrolase in wild-type and PARG-110 knock-out retina.
Sahaboglu A; Bolz S; Löwenheim H; Paquet-Durand F
Adv Exp Med Biol; 2014; 801():463-9. PubMed ID: 24664732
[TBL] [Abstract][Full Text] [Related]
13. New Insights into the Roles of NAD+-Poly(ADP-ribose) Metabolism and Poly(ADP-ribose) Glycohydrolase.
Tanuma S; Sato A; Oyama T; Yoshimori A; Abe H; Uchiumi F
Curr Protein Pept Sci; 2016; 17(7):668-682. PubMed ID: 27817743
[TBL] [Abstract][Full Text] [Related]
14. Disrupted ADP-ribose metabolism with nuclear Poly (ADP-ribose) accumulation leads to different cell death pathways in presence of hydrogen peroxide in procyclic Trypanosoma brucei.
Schlesinger M; Vilchez Larrea SC; Haikarainen T; Narwal M; Venkannagari H; Flawiá MM; Lehtiö L; Fernández Villamil SH
Parasit Vectors; 2016 Mar; 9():173. PubMed ID: 27007296
[TBL] [Abstract][Full Text] [Related]
15. A nonradiometric, high-throughput assay for poly(ADP-ribose) glycohydrolase (PARG): application to inhibitor identification and evaluation.
Putt KS; Hergenrother PJ
Anal Biochem; 2004 Oct; 333(2):256-64. PubMed ID: 15450800
[TBL] [Abstract][Full Text] [Related]
16. Functional Role of ADP-Ribosyl-Acceptor Hydrolase 3 in poly(ADP-Ribose) Polymerase-1 Response to Oxidative Stress.
Mashimo M; Moss J
Curr Protein Pept Sci; 2016; 17(7):633-640. PubMed ID: 27090906
[TBL] [Abstract][Full Text] [Related]
17. Mono-galloyl glucose derivatives are potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors and partially reduce PARP-1-dependent cell death.
Formentini L; Arapistas P; Pittelli M; Jacomelli M; Pitozzi V; Menichetti S; Romani A; Giovannelli L; Moroni F; Chiarugi A
Br J Pharmacol; 2008 Dec; 155(8):1235-49. PubMed ID: 18806807
[TBL] [Abstract][Full Text] [Related]
18. PARG Inhibitors and Functional PARG Inhibition Models.
Sasaki Y; Hozumi M; Fujimori H; Murakami Y; Koizumi F; Inoue K; Masutani M
Curr Protein Pept Sci; 2016; 17(7):641-653. PubMed ID: 27817742
[TBL] [Abstract][Full Text] [Related]
19. Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase.
Gravells P; Grant E; Smith KM; James DI; Bryant HE
DNA Repair (Amst); 2017 Apr; 52():81-91. PubMed ID: 28254358
[TBL] [Abstract][Full Text] [Related]
20. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
Gao H; Coyle DL; Meyer-Ficca ML; Meyer RG; Jacobson EL; Wang ZQ; Jacobson MK
Exp Cell Res; 2007 Mar; 313(5):984-96. PubMed ID: 17276427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
